Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00649506 | Food Study of Nitrofurantoin Macrocrystals 100 mg Capsules and Macrodantin® 100 mg | PHASE1 | COMPLETED | 28 | — | — | Sep 1, 2003 | Sep 1, 2003 | Apr 24, 2024 | 1 | United States |
| Arm | Type | Description |
|---|---|---|
| 1 | EXPERIMENTAL | Nitrofurantoin Macrocrystals 100 mg Capsules |
| 2 | ACTIVE_COMPARATOR | Macrodantin® 100 mg Capsules |
| Name | Type | Description |
|---|---|---|
| Nitrofurantoin Macrocrystals 100 mg Capsules | DRUG | 100mg, single dose fed |
| Macrodantin® 100 mg Capsules | DRUG | 100mg, single dose fed |
Inclusion Criteria: 1. Age: 18 years and older. 2. Sex: Male and/or non-pregnant, non-lactating female 1. Women of childbearing potential must have negative serum Beta-human chorionic gonadotropin (HCG) pregnancy tests performed within 14 days prior to of the study and on the evening prior to e...